Insurers need to balance hyper-personalisation against the risk of fragmenting risk pools into statistically unreliable segments, industry experts say.
Formed after the sale of NSM’s US commercial division, Ignyte now manages over US$650m in premiums in niche specialty segments across the US, Europe, and Australia.
